Van Andel Starts Translational Cancer Program | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Van Andel Research Institute (VARI) has started a new pediatric cancer research program that will focus on using molecular analysis and personalized medical approaches, VARI said today.

The VARI Pediatrics Cancer Translational Research Program will use genomic techniques to develop treatments for children with cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.